Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.
腸道荷爾蒙基藥理學:新型配方及未來代謝疾病治療的可能性。
Diabetologia 2023-09-15
Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity.
葡萄糖素激動劑在治療代謝性疾病,包括第2型糖尿病和肥胖症中的應用。
Diabetes Obes Metab 2024-06-10
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.
肥胖症和第二型糖尿病藥物治療的新發展 - GLP-1 受體激動劑的範疇內和範疇外。
Biomedicines 2024-06-27
Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes.
評估新型 GLP-1 受體激動劑在 2 型糖尿病中的治療和毒理特徵。
Expert Opin Drug Metab Toxicol 2024-09-13